Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

507 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sequences of clustered epitopes in Gag and Nef potentially presented by predominant class I human leukocyte antigen (HLA) alleles A and B expressed by human immunodeficiency virus type 1 (HIV-1)-infected patients in Vietnam.
Lazaro E, Theodorou I, Legrand E, Recordon-Pinson P, Boucher S, Capoulade C, Lan TH, Hung PV, Debre P, Fleury H. Lazaro E, et al. AIDS Res Hum Retroviruses. 2005 Jun;21(6):586-91. doi: 10.1089/aid.2005.21.586. AIDS Res Hum Retroviruses. 2005. PMID: 15989466
Susceptibility to antiretroviral drugs of CRF01_AE, CRF02_AG, and subtype C viruses from untreated patients of Africa and Asia: comparative genotypic and phenotypic data.
Fleury HJ, Toni T, Lan NT, Hung PV, Deshpande A, Recordon-Pinson P, Boucher S, Lazaro E, Jauvin V, Lavignolle-Aurillac V, Lebel-Binay S, Cheret A, Masquelier B. Fleury HJ, et al. Among authors: lazaro e. AIDS Res Hum Retroviruses. 2006 Apr;22(4):357-66. doi: 10.1089/aid.2006.22.357. AIDS Res Hum Retroviruses. 2006. PMID: 16623640
Interpretation of genotype and pharmacokinetics for resistance to fosamprenavir-ritonavir-based regimens in antiretroviral-experienced patients.
Pellegrin I, Breilh D, Coureau G, Boucher S, Neau D, Merel P, Lacoste D, Fleury H, Saux MC, Pellegrin JL, Lazaro E, Dabis F, Thiébaut R; ANRS Co3 Aquitaine Cohort. Pellegrin I, et al. Among authors: lazaro e. Antimicrob Agents Chemother. 2007 Apr;51(4):1473-80. doi: 10.1128/AAC.00481-06. Epub 2007 Feb 12. Antimicrob Agents Chemother. 2007. PMID: 17296739 Free PMC article.
CMV plasma DNAemia and risk of cancer among HIV-infected patients: a case-control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002-2007.
Bruyand M, Vandenhende MA, Marcel G, Lazaro E, Lafon ME, Dupon M, Dabis F, Geffard S, Fleury H, Faure-Della Corte M, Bonnet F, Thiebaut R, Garrigue I. Bruyand M, et al. Among authors: lazaro e. J Clin Virol. 2011 Feb;50(2):177-80. doi: 10.1016/j.jcv.2010.10.021. Epub 2010 Dec 3. J Clin Virol. 2011. PMID: 21126905
Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012.
Morlat P, Vivot A, Vandenhende MA, Dauchy FA, Asselineau J, Déti E, Gerard Y, Lazaro E, Duffau P, Neau D, Bonnet F, Chêne G; Groupe D’epidémiologie Clinique du Sida en Aquitaine (Gecsa). Morlat P, et al. Among authors: lazaro e. PLoS One. 2013 Jun 12;8(6):e66223. doi: 10.1371/journal.pone.0066223. Print 2013. PLoS One. 2013. PMID: 23776637 Free PMC article.
Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure.
Vandenhende MA, Bellecave P, Recordon-Pinson P, Reigadas S, Bidet Y, Bruyand M, Bonnet F, Lazaro E, Neau D, Fleury H, Dabis F, Morlat P, Masquelier B. Vandenhende MA, et al. Among authors: lazaro e. PLoS One. 2014 Jan 27;9(1):e86771. doi: 10.1371/journal.pone.0086771. eCollection 2014. PLoS One. 2014. PMID: 24475178 Free PMC article.
507 results